ADAMTS1 and ovarian cancer: However, it is not clear why there was a parallel increase in TIMP-3 expression, the tissue inhibitor of ADAMTS-1 and ADAMTS-5, in malignant ovarian neoplasms compared to benign epithelial ovarian neoplasm [227].